[Common name] :Ibuprofen sustained release capsules
【冰球突破官方平台】 :Bu luo fen huan shi jiao nang
[English name] :Ibuprofen Sustained-Release capsules
Product description
【冰球突破mg平台】 Each capsule contains ibuprofen 0.3克。Excipients: sucrose, corn starch, povidone K30。
【冰球突破mg平台】 The contents of this product are white spherical pellets。
【冰球突破官方平台】 This product is antipyretic analgesic over-the-counter drugs。
Used to relieve mild to moderate pain such as headache, joint pain, migraine, toothache, muscle pain, neuralgia, dysmenorrhea。Also commonly used
Fever caused by a cold or influenza。
【冰球突破mg平台】0.3克
[Usage and Dosage] Oral。Adults take 1 tablet once, twice a day (once in the morning and once in the evening)。
【冰球突破mg平台】
1.In a small number of patients, nausea, vomiting, burning or mild indigestion, gastrointestinal ulcers and bleeding, elevated aminotransferase, headache, dizziness, tinnitus, blurred vision, nervousness, drowsiness, lower limb edema, or sudden weight gain may occur。
2.Rare rash, allergic nephritis, cystitis, nephrotic syndrome, renal papillary necrosis or renal failure, bronchospasm。
【冰球突破官方平台】
1.It should not be used in people who are allergic to other non-steroidal anti-inflammatory drugs。
2.Prohibited for pregnant and lactating women。
3.Contraindicated for asthma patients who are allergic to aspirin。
【冰球突破官方平台】
1.This product is symptomatic treatment drug, should not be used for a long time or a large number of days, for pain should not exceed 5 days, for antipyretic should not exceed 3 days, if the symptoms do not relieve, please consult the doctor or pharmacist
2.It must be swallowed whole, not opened or dissolved。
3.Do not take other medicines containing antipyretic and analgesic drugs (such as some combination anti-cold drugs) at the same time.。
4.Do not drink alcohol or beverages containing alcohol while taking this product。
5.Use with caution in patients over 60 years of age, bronchial asthma, liver and kidney insufficiency, coagulation mechanism or platelet dysfunction (such as hemophilia)。
6.Patients with the following conditions should be used under the guidance of a physician: a history of peptic ulcer, gastrointestinal bleeding, cardiac insufficiency, hypertension。
7.In case of overdose or serious adverse reactions, seek medical attention immediately。
8.Use with caution if allergic to this product。
9.Do not use this product when the character changes
10.Keep this product out of reach of children。
11.If you are using other drugs, please consult your doctor or pharmacist before using this product。
12.If there is blood or ulcers in the gastrointestinal tract, chest pain, shortness of breath, weakness, vague speech, etc., the drug should be stopped and consult a doctor。
13.If rash or allergic symptoms occur after first use of this product, discontinue the drug and consult a doctor。
【冰球突破mg平台】
1.When used with other antipyretic, analgesic and anti-inflammatory drugs, this product can increase gastrointestinal adverse reactions and may lead to ulcers。
2.When used with heparin, dicoumarin and other anticoagulants, prothrombin time can be prolonged and bleeding tendency can be increased。
3.When used with digoxin, methotrexate and oral hypoglycemic drugs, it can increase the blood concentration of these drugs and should not be used together。
4.When used with furosemide (furanoanilic acid), the latter's sodium excretion and antihypertensive effect is weakened: when used with antihypertensive drugs, the latter's antihypertensive effect is also reduced。
5.Drug interactions may occur if used with other drugs. Please consult your doctor or pharmacist for details。
【冰球突破官方平台】 This product can inhibit the synthesis of prostaglandin, has analgesic, antipyretic and anti-inflammatory effects。And it is a slow-release dosage form, which can gradually release the drug in the body。Each dose lasts 12 hours for pain relief。
【冰球突破mg平台】 Sealed storage
[Packaging] Aluminum plastic packaging,10 pieces/board X2 board/box。
[Effective period] 36 months
[Executive Standard] "Chinese Pharmacopoeia" 2015 edition II
[Approval number] National Drug approval number H20093691